Skip to main content
TipRanks
Go Ultimate75% OFF

Pharming Group (0QCO) Financial Statements

5 Followers

Pharming Group Financial Overview

Pharming Group's market cap is currently €807.58M. The company's EPS TTM is €0.04; its P/E ratio is 35.72; Pharming Group is estimated to report earnings on March 18, 2027, and the estimated EPS forecast is €0.01. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 376.13M€ 297.07M€ 245.32M€ 205.62M€ 198.87M
Gross Profit€ 330.63M€ 261.80M€ 220.10M€ 188.06M€ 165.73M
Operating Income€ 20.88M€ -3.67M€ -4.88M€ 18.23M€ 19.01M
EBITDA€ 34.78M€ 7.55M€ 9.88M€ 33.53M€ 33.76M
Net Income€ 2.97M€ -11.84M€ -10.55M€ 13.67M€ 15.34M
Balance Sheet
Cash & Short-Term Investments€ 179.88M€ 167.82M€ 213.42M€ 208.58M€ 191.92M
Total Assets€ 500.02M€ 400.61M€ 462.85M€ 425.80M€ 397.42M
Total Debt€ 115.79M€ 112.26M€ 171.54M€ 167.69M€ 161.76M
Net Debt€ -30.29M€ 57.34M€ 109.80M€ -40.89M€ -29.41M
Total Liabilities€ 222.89M€ 178.85M€ 244.07M€ 221.16M€ 204.45M
Stockholders' Equity€ 277.10M€ 221.76M€ 218.78M€ 204.64M€ 192.92M
Cash Flow
Free Cash Flow€ 51.18M€ -2.58M€ -18.77M€ 20.92M€ 22.86M
Operating Cash Flow€ 51.96M€ -1.86M€ -17.30M€ 22.90M€ 31.58M
Investing Cash Flow€ 19.13M€ 32.74M€ -129.39M€ 5.32M€ -23.06M
Financing Cash Flow€ 15.03M€ -35.63M€ -1.04M€ -4.98M€ -22.54M

Currency in EUR

Pharming Group Earnings and Revenue History

-200M0200M400M-100 %-50 %0 %50 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Pharming Group Liabilities to Assets

0200M400M600M40 %60 %80 %100 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Pharming Group Cash Flow

-150M-100M-50M050M100M201720182019202020212022202320242025OperatingInvestingFinancing

Pharming Group Forecast EPS vs Actual EPS

0000000Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss